Eli Lilly & Co. Stock Falls 3.8%, Underperforms Peers

Dow Jones01-16

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Eli Lilly & Co. slipped 3.8% to $1,032.97 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.3% to 6,944.47 and the Dow Jones Industrial Average rising 0.6% to 49,442.44.

This was the stock's third consecutive day of losses.

Eli Lilly & Co. closed 8.9% short of its 52-week high of $1,133.95, which the company reached on January 8th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 0.5% to $219.57, Pfizer Inc. rose 1.2% to $25.89, and AbbVie Inc. fell 2.32% to $216.75.

Trading volume totaled 4.2 million, compared to the 50-day average of 3.6 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

January 15, 2026 16:35 ET (21:35 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment